Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.180
0.00 (0.00%)
Apr 10, 2024, 10:53 AM EDT - Market open

PLSH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
2.381.632.069.020.350000
Revenue Growth (YoY)
46.59%-21.01%-77.16%2508.69%-----
Cost of Revenue
2.121.231.527.022.050000.02
Gross Profit
0.270.40.542-1.7000-0.02
Selling, General & Admin
5.811.091.522.818.950000
Research & Development
00000.020.30.360.370.08
Other Operating Expenses
04.74.564.454.122.142.771.230.29
Operating Expenses
5.815.796.087.268.972.443.121.60.37
Operating Income
-5.55-5.4-5.54-5.26-10.67-2.44-3.12-1.6-0.39
Interest Expense
0.682.051.111.510.48-0.46-0.0700
Other Expense / Income
1.791.7-1.86-1.54-1.132.370.80-0.03
Pretax Income
-8.02-9.14-4.78-5.23-10.02-4.34-3.86-1.6-0.36
Income Tax
01.961.341.76-0.540000
Net Income
-8.02-11.1-6.12-6.99-9.48-4.34-3.86-1.6-0.36
Shares Outstanding (Basic)
1715181715341915
Shares Outstanding (Diluted)
1715181715341915
Shares Change
11.88%-16.60%5.35%1297.20%-74.59%-85.97%76.62%26.89%-
EPS (Basic)
-0.48-0.75-0.34-0.41-7.83-0.91-0.11-0.08-0.02
EPS (Diluted)
-0.48-0.75-0.34-0.41-7.83-0.91-0.11-0.08-0.02
Free Cash Flow
-1.59-2.64-4.09-10.85-6.29-0.47-1.23-0.89-0.64
Free Cash Flow Per Share
-0.10-0.18-0.23-0.64-5.19-0.10-0.04-0.05-0.04
Gross Margin
11.13%24.37%26.25%22.15%-491.92%----9583.10%
Operating Margin
-232.55%-331.81%-269.00%-58.31%-3087.46%----182661.50%
Profit Margin
-336.08%-682.14%-297.35%-77.57%-2742.81%----168064.32%
Free Cash Flow Margin
-66.66%-162.47%-198.34%-120.28%-1818.88%----300478.87%
EBITDA
-3.83-3.41-4.34-4.66-9.78-2.44-3.12-1.6-0.39
EBITDA Margin
-160.72%-209.44%-210.66%-51.69%-2829.33%----181897.65%
Depreciation & Amortization
1.711.730.970.340.890.410.0500
EBIT
-5.55-5.14-5.3-5.01-10.67-2.84-3.18--0.39
EBIT Margin
-232.55%-315.84%-257.52%-55.52%-3087.46%----182661.50%
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.